loader
Please Wait
Applying Filters...

Digital Content for Ulixertinib

Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/biomed-valley-discoveries-announces-first-patient-dosed-in-phase-ii-combination-trial-with-ulixertinib-bvd-523-its-first-in-class-and-best-in-class-erk-inhibitor-in-combination-with-hydroxychloroquine-301621646.html

PRNEWSWIRE
12 Sep 2022